Sign in →

Test ID NBLD0752 MayoComplete Plasma Cell Myeloma, Next-Generation Sequencing, Varies

Useful For

Evaluating multiple myeloma at the time of diagnosis and at disease relapse or when changing clinical management to provide prognostic information and determine potential therapeutic implications

Specimen Type

Varies


Shipping Instructions


Bone marrow aspirate samples must arrive within 4 days of collection.



Specimen Required


Submit only 1 of the following specimens:

 

Preferred:

Specimen Type: Bone marrow aspirate

Container/Tube: Lavender or pink top (EDTA) or yellow top (ACD)

Specimen Volume: 2 mL

Collection Instructions:

1. Minimum plasma cell percentage is 5%.

2. Invert several times to mix bone marrow.

3. Send bone marrow specimen in original tube. Do not aliquot.

4. Label specimen as bone marrow.

5. Fresh specimen is required for this test, as testing is performed on sorted cells.

Specimen Stability Information: Ambient (preferred) 4 days/Refrigerate

Additional Information: To ensure minimum volume and concentration of DNA are met, the requested volume must be submitted. Testing may be canceled if DNA requirements are inadequate.

 

Specimen Type: Paraffin-embedded bone marrow clot

Container/Tube: Paraffin block

1. Send 1 hematoxylin and eosin-stained slide in addition to the paraffin block.

2. Minimum plasma cell percentage is 20%.

3. Required amount of tissue area is at least 25 mm(2).

4. Tissue should be fixed in 10% neutral-buffered formalin. Other fixatives are not acceptable.

5. Decalcified specimens (eg, bone marrow core biopsies) are not acceptable.

Specimen Stability Information: Ambient

Additional Information: If the quality of the specimen is poor or the plasma cell population is below 20%, testing should not be ordered. Testing may be canceled if DNA requirements are inadequate.

 

Acceptable:

Specimen Type: Tissue slide, bone marrow clot

Slides: 20 unstained slides

Container/Tube: Transport in plastic slide holders.

Collection Instructions:

1. Send 20 unstained, nonbaked slides with 5-micron thick sections of tissue and 1 hematoxylin and eosin-stained slide.

2. Minimum amount of plasma cell percentage is 20%.

4. Required amount of tissue area is at least 25 mm(2).

5. Tissue should be fixed in 10% neutral-buffered formalin. Other fixatives are not acceptable.

6. Decalcified specimens (eg, bone marrow core biopsies) are not acceptable.

Specimen Stability Information: Ambient

Additional Information:

1. Testing may be canceled if resultant extracted DNA does not meet concentration requirements.

2. Broken or cracked unstained slides will be rejected. Stained slides that were broken and repaired (ie, double mounted) at the client site will not be rejected, as, in most cases, they can still be reviewed under the microscope. However, due to the double mounting, digital scanning cannot be performed.


Specimen Minimum Volume

Bone marrow aspirate: 1 mL; Tissue slides: 10 unstained slides

Specimen Stability Information

Specimen Type Temperature Time
Varies Varies

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Specimens that have been decalcified (all methods) Reject
Bone marrow core biopsies Reject
Paraffin shavings Reject
Frozen tissue Reject
Extracted DNA Reject
Moderately to severely clotted bone marrow aspirate Reject
Broken or cracked unstained slides Reject
Broken or cracked stained slides that cannot be repaired Reject

Day(s) Performed

Monday through Friday

Report Available

16 to 21 days

Method Name

Next-Generation Sequencing (NGS)

Reporting Name

Plasma Cell Myeloma, NGS, V

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Secondary ID

618479

CPT Code Information

81450

Reference Values

An interpretive report will be provided.

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

Testing Algorithm

For a list of the genes and exons targeted by this assay, see Targeted Genes Interrogated by MayoComplete Plasma Cell Myeloma Next-Generation Sequencing.

Forms

1. Hematopathology Patient Information (T676)

2. If not ordering electronically, complete, print, and send an Hematopathology/Cytogenetics Test Request (T726) with the specimen.

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
CSPMM NGPCM Pre-Analysis Cell Sorting, BM No No
Sanford Laboratories - Enterprise Additional Information:

SANFORD LABORATORY INTERFACE BUILD INFORMATION

 Result Code     Result Code Description   
 29715  Specimen Type
 29716  Indication for Test
 29717  NGPCM Result
 29718  Pathogenic Mutations Detected   
 29719  Interpretation
 29720  Variants of Unknown Significance   
 29721  Additional Information
 29722  Clinical Trials
 29723  Method Summary
 29724  Disclaimer
 29725  Panel Gene List
 29726  Reviewed By

REFLEX TEST

 Result Code     Result Code Description   
 29727  NGPCM Pre-Analysis Cell Sort   
 29728  Final Diagnosis